Baycol (cerivastatin) is a small molecule pharmaceutical. Cerivastatin was first approved as Baycol on 1997-06-26. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.
|Indication||coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia|
|Drug Class||Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)|